151751-Najiba-Chargi

340 CHAPTER 17 Appendix 8. (Continued). VSA > 80% at t 1 n = 24 VSA < 80% t 1 n = 33 Univariable logistic regression analysis OR (95%CI) P value T4 4 (17) 7 (21) 1.5 (0.3-7.5) .600 HPV status Negative 7 (30) 9 (28) 1.0 Positive 16 (70) 23 (72) 1.1 (0.3-3.6) .852 Unknown 1 1 Treatment modality .108 RT 13 (54) 9 (27) 1.0 CRT (cetuximab) 2 (8) 7 (21) 5.1 (0.8-30.2) .075 CRT (cisplatin) 9 (38) 17 (52) 2.7 (0.8-8.8) .093 Pretreatment VSA < 80% No 17 (77) 14 (48) 1.0 Yes 4 (24) 15 (52) 4.6 (1.2-16.9) .023 Unknown 3 4 NB: Not all percentages sum up exactly to 100% due to rounding.Abbreviations: BMI = body mass index, CI = confidence interval, CRT = chemoradiotherapy (cisplatin or cetuximab based), HPV = human papilloma virus, FOIS = functional oral intake scale, OR = odds ratio, other = soft palate, uvula, oropharyngeal wall, vallecula or pharyngeal arch, RT = radiotherapy, sarcopenia = SMM below 43.2 cm 2 /m 2 , SMM = skeletal muscle mass, VSA = vowel space area.